MINISTERIAL INSTRUCTION DETERMINING THECONDITIONS AND MODALITIES FOR HEALTH CARE DELIVERY TO PERSONS LIVING WITH HIV/AIDS.
CONDITIONS FOR ACCESS TO TREATMENT UNDER ARV/P, MOI/P, STD/P, RL/P, AP/P
Article 11:Beneficiaries of the treatment programme shall fulfill the following conditions:
Must have gone through one of the following points for enrolment in the: VCTI, VCT, PMTCT programmes or selected by the Patient Selection Committees set up in hospitals approved for the prescription of ARV/P drugs.
Must have a fixed residence in Rwanda(at least six months within the geographical area served by the health care delivery institution).
Must be totally or partly unable to pay for treatment.
Must meet the clinical and biological criteria established by the Ministry responsible for HIV/AIDS Control.
Must consent to make a financial contribution, according to category.
Must consent to become a member of a compulsory sick insurance/mutual insurance scheme, provided it exists within the area of operation or covers the applicant's occupational group.
Indigents or very low income earners who will not be required under the programme to make financial contributions for medical therapy administered to them under the (ARV/P, MOI/P, STD/P, LR/P, AP/P) programmes and/or for consultations and hospital admission must consent to become members of a mutual insurance scheme, or at least become members of the PLWHA association or of PLWHA support groups recognized by the national network of persons living with HIV.
Must have revealed the serological status to a member of the family or to a close acquaintance.
Must consent in writing to regular home visits by the health workers.
Must consent in writing to stay on long-term medication.
Must have a close relation to ensure follow-up and compliance.
Must undertake to practice safe sex.
Must undertake not to get drugs through another programme.
Source :www.tracrwanda.org.rw/Reports.htm National Policies and Protocols - Instruction Ministérielle déterminant les Conditions et Modalités de Prise en Charge Thérapeutique des Personnes vivant avec le VIH/SIDA